New Class of Protein Could Treat Cancer and Other Diseases

Researchers at Georgia State University have designed a protein that can effectively target a cell surface receptor linked to a number of diseases, including cancer. The researchers believe this synthetic protein, which they named ProAgio, has the potential to be a therapeutic treatment for various illnesses. Their work was recently published in Nature Communications. The 

Continue Reading…

Researchers Generate Stem Cell-Derived Beta Cells

Type 1 diabetes (T1D) is an autoimmune disease where an individual’s immune cells destroy the beta cells of the pancreas. Beta cells are responsible for the production and secretion of insulin, a hormone that allows the body to use or store glucose from foods. People with T1D suffer from high blood glucose that can result 

Continue Reading…

What is a monobody?

Here at Kerafast, we recently added the first monobody products to our catalog, prompting us to ask the question: what exactly is a monobody? Monobodies, as it turns out, are actually synthetic binding proteins. Based on a molecular scaffold composed of a fibronection type III domain (FN3), they are an alternative to traditional antibodies, belonging 

Continue Reading…